NO844610L - Konsentrat av den anti-hemofile faktor viii og fremgangsmaate for fremstilling derav - Google Patents

Konsentrat av den anti-hemofile faktor viii og fremgangsmaate for fremstilling derav

Info

Publication number
NO844610L
NO844610L NO84844610A NO844610A NO844610L NO 844610 L NO844610 L NO 844610L NO 84844610 A NO84844610 A NO 84844610A NO 844610 A NO844610 A NO 844610A NO 844610 L NO844610 L NO 844610L
Authority
NO
Norway
Prior art keywords
hemofile
concentrate
procedure
producing
factor viii
Prior art date
Application number
NO84844610A
Other languages
English (en)
Other versions
NO169875C (no
NO169875B (no
Inventor
Mirella Ezban Rassmusen
Ole Nordfang
Original Assignee
Nordisk Insulinlab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27220842&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO844610(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from DK127483A external-priority patent/DK127483D0/da
Priority claimed from DK549483A external-priority patent/DK157170C/da
Application filed by Nordisk Insulinlab filed Critical Nordisk Insulinlab
Publication of NO844610L publication Critical patent/NO844610L/no
Publication of NO169875B publication Critical patent/NO169875B/no
Publication of NO169875C publication Critical patent/NO169875C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/827—Proteins from mammals or birds
    • Y10S530/829—Blood
    • Y10S530/83—Plasma; serum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
NO84844610A 1983-05-09 1984-11-20 Fremgangsmaate for fremstilling av et konsentrat av den anti-hemofile faktor viii NO169875C (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DK127483A DK127483D0 (da) 1983-05-09 1983-05-09 Fremgangsmade til fremstilling af et koncentrat af den anti-hemofile faktor viii
DK549483A DK157170C (da) 1983-05-09 1983-12-01 Koncentrat af den anti-hæmofile Faktor VIII samt fremgangsmåde til fremstilling deraf
DK64684A DK64684A (da) 1983-05-09 1984-02-14 Fremgangsmaade til fremstilling af et koncentrat af den anti-haemofile faktor viii
PCT/DK1984/000019 WO1984003628A1 (en) 1983-05-09 1984-03-20 A concentrate of the antihemophilic factor viii and a process for producing it

Publications (3)

Publication Number Publication Date
NO844610L true NO844610L (no) 1984-11-20
NO169875B NO169875B (no) 1992-05-11
NO169875C NO169875C (no) 1992-08-19

Family

ID=27220842

Family Applications (1)

Application Number Title Priority Date Filing Date
NO84844610A NO169875C (no) 1983-05-09 1984-11-20 Fremgangsmaate for fremstilling av et konsentrat av den anti-hemofile faktor viii

Country Status (6)

Country Link
US (1) US4650858A (no)
EP (1) EP0148843B2 (no)
DE (1) DE3481109D1 (no)
FI (1) FI80382C (no)
NO (1) NO169875C (no)
WO (1) WO1984003628A1 (no)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
GB8505882D0 (en) * 1985-03-07 1985-04-11 Central Blood Lab Authority Purification of blood coagulation factor viii
DE3625090A1 (de) * 1986-07-24 1988-01-28 Behringwerke Ag Mittel zur therapie faktor viii-resistenter haemophilie a und verfahren zu seiner herstellung
ATE112287T1 (de) * 1987-12-21 1994-10-15 Miles Inc Faktor viii- gelfiltration.
ATE90875T1 (de) * 1989-05-24 1993-07-15 Miles Inc Gelfiltration von waermebehandeltem faktor viii.
DE4111393A1 (de) * 1991-04-09 1992-10-15 Behringwerke Ag Stabilisierte faktor viii-praeparationen
WO1993022336A1 (en) * 1992-04-30 1993-11-11 Alpha Therapeutic Corporation Improved solubilization and stabilization of factor viii complex
US5330974A (en) * 1993-03-01 1994-07-19 Fibratek, Inc. Therapeutic fibrinogen compositions
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
EP2921180B1 (en) 1999-02-22 2019-08-14 University of Connecticut Albumin-free factor VIII formulations
WO2004075923A2 (en) * 2003-02-26 2004-09-10 Nektar Therapeutics Al, Corporation Polymer-factor viii moiety conjugates
RU2326689C1 (ru) * 2007-03-13 2008-06-20 Общество с ограниченной ответственностью "БиоГениус" Способ получения концентрата viii фактора свертывания крови человека и продукт его содержащий
NZ593190A (en) 2008-11-07 2013-01-25 Baxter Int Factor viii formulations
KR102170375B1 (ko) 2009-06-09 2020-10-27 프로롱 파마슈티컬스, 엘엘씨 헤모글로빈 조성물
WO2013039449A1 (en) * 2011-09-16 2013-03-21 Ge Healthcare Bio-Sciences Ab Plasma protein fractionation by sequential polyacid precipitation
US12478488B2 (en) 2020-02-19 2025-11-25 Medinol Ltd. Helical stent with enhanced crimping

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3652530A (en) * 1967-08-28 1972-03-28 American Nat Red Cross Antihemophilic factor prepared from blood plasma using polyethylene glycol
US3631018A (en) * 1970-05-01 1971-12-28 Baxter Laboratories Inc Production of stable high-potency human ahf using polyethylene glycol and glycine to fractionate a cryoprecipitate of ahf concentrate
US3682881A (en) * 1970-10-02 1972-08-08 Baxter Laboratories Inc Fractionation of plasma using glycine and polyethylene glycol
US4069216A (en) * 1975-06-16 1978-01-17 Edward Shanbrom, Inc. Simplified methods for preparation of very high purity Factor VIII concentrate
US4027013A (en) * 1976-01-22 1977-05-31 William L. Wilson Clottable fibrinogen free factor VIII and albumin product and process
JPS52125609A (en) * 1976-04-09 1977-10-21 Green Cross Corp:The Purification of agglutination factor viii
DE2916711A1 (de) * 1979-04-25 1980-11-06 Behringwerke Ag Blutgerinnungsfaktoren und verfahren zu ihrer herstellung
FR2460305A2 (fr) * 1979-06-29 1981-01-23 Merieux Inst Procede de preparation d'un concentre de facteur viii
SE448945B (sv) * 1979-12-20 1987-03-30 Blombaeck E G B Forfarande for rening och /eller koncentrering av faktor viii-komplexet
US4289691A (en) * 1980-01-18 1981-09-15 The Canadian Red Cross Society Method of obtaining intermediate purity factor VIII
US4386068A (en) * 1980-02-26 1983-05-31 Cutter Laboratories, Inc. Antihemophilic factor concentrate and method for preparation
AT369263B (de) * 1980-08-27 1982-12-27 Immuno Ag Verfahren zur herstellung eines faktor viii(ahf) -hochkonzentrates
DE3279292D1 (en) * 1981-04-08 1989-01-26 Atomic Energy Authority Uk Blood fractionation improvement
US4435318A (en) * 1981-05-22 1984-03-06 Ionics, Incorporated Electrodialysis preparation of purified AHF concentrate
JPS5874617A (ja) * 1981-10-28 1983-05-06 Green Cross Corp:The 人由来血液凝固第７因子含有水溶液の加熱処理方法
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4478825A (en) * 1983-10-14 1984-10-23 Armour Pharmaceutical Company Warm ethanol method for preparation of low fibrinogen antihemophilic factor
US4508709A (en) * 1983-12-05 1985-04-02 Armour Pharmaceutical Company Process for purifying factor VIII:C
US4486410A (en) * 1984-02-09 1984-12-04 Armour Pharmaceutical Company Heat defibrinogenation of AHF preparation
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate

Also Published As

Publication number Publication date
FI80382C (fi) 1990-06-11
EP0148843A1 (en) 1985-07-24
FI844557A0 (fi) 1984-11-20
WO1984003628A1 (en) 1984-09-27
NO169875C (no) 1992-08-19
EP0148843B2 (en) 1994-05-04
EP0148843B1 (en) 1990-01-24
FI80382B (fi) 1990-02-28
US4650858A (en) 1987-03-17
DE3481109D1 (de) 1990-03-01
NO169875B (no) 1992-05-11
FI844557L (fi) 1984-11-20

Similar Documents

Publication Publication Date Title
DK292385D0 (da) Fremstilling af faktor viii og beslaegtede produkter.
NO844610L (no) Konsentrat av den anti-hemofile faktor viii og fremgangsmaate for fremstilling derav
NO843956L (no) Fremgangsmaate for fremstilling av karboksyalkenamido-cefalosporiner
DE3472624D1 (en) Instrument for the treatment of respiratory obstruction
NO169591C (no) Fremgangsmaate for fremstilling av n-alkylerte dipeptider og deres estere
GR80171B (en) N-(2-nitrophenyl)-4-aminopyrimidine derivatives process for the preparation thereof and use
DK55287D0 (da) Neuritaktiverende faktor og fremgangsmaade til fremstilling deraf
TR22082A (tr) Polimerizasyon dereceli buten-1'in istihsali icin usul
IT1206707B (it) Apparecchio per l'applicazione di forza.
NO843562L (no) Ekstra kraftig slangekopling og fremgangsmaate for fremstilling av slange-kopling-forbindelse
DK161389C (da) Tekstilstofblegemiddel og fremgangsmaade til fremstilling deraf
DE68928619D1 (de) Verfahren zur Herstellung von mono-N-alkylierten Polyazamacrocyclen
NO170019C (no) Fremgangsmaate for fremstilling av deglucoteicoplanin (antibiotikum l 17392)
NO845207L (no) Fremgangsmaate for fremstilling av diaminopolyalkenyletere
DE3465342D1 (en) Process for the preparation of titanium dioxide
FI830542A0 (fi) Foerfarande foer behandling av den fraon en cellulosas kokningsprocess erhaollna cellulosan
NO156383C (no) Vernegitter e.l. og framgangsmŸte for tilvirking av dette.
DK395084D0 (da) Quinoloner og fremgangsmaade til fremstilling deraf
IT1179025B (it) Procedimento per la produzione di l'isoleucina
NO159764C (no) Fremgangsmaate og anordning ved fremstilling av pariserpoteter.
DK160200C (da) Beholderlukke og fremgangsmaade til fremstilling af samme
DE3360856D1 (en) Pregnane derivatives and method of producing the same
DK549483D0 (da) Koncentrat af den anti-haemofile faktor viii samt fremgangsmade til fremstilling deraf
NO844809L (no) Fremgangsmaate for fremstilling av polyfenylenoksyd
SE8400605D0 (sv) Process and equipment for the preparation of mechanical pulp